Skip to content
Screener

Halozyme Therapeutics HALO Shares acquired, commission fees, cost per share (in dollars per share)

Shares acquired, commission fees, cost per share (in dollars per share) at other companies

Burford Capital logo
Burford CapitalBUR
$12.71-9.6%
Burford Capital logo
Burford CapitalBUR
$12.71-9.6%
AMN Healthcare logo
AMN HealthcareAMN
$23.78—
AMN Healthcare logo
AMN HealthcareAMN
$95.13—
Kaltura, Inc. logo
Kaltura, Inc.KLTR
$0—
Redwire logo
RedwireRDW
$1.72-74.9%

Other financials

Income statement

See full
Revenue$481.0M+47.7%
Gross profit$401.8M+43.8%
Operating income$287.7M+42.1%
Net income$229.9M+39.2%
EPS (diluted)$1.90+42.9%

Balance sheet

See full
Cash & equivalents$164.0M+165%
Total debt$2.2B+41.6%
Total equity$143.5M-56.9%
Total assets$2.6B+25.5%

Cash flow

See full
Operating cash flow$240.9M+142%
CapEx$4.2M+167%
Free cash flow$236.7M+141%

Valuation

See full
Market cap$12.23B+66.3%
Enterprise value$14.25B+61.3%
P/E17×-4.9×
P/S7.4×+1.1×

Profitability

See full
Gross margin82.4%-1.8pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin48.5%+2.6pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity15.2×+10.6×
Current ratio2.7×-5.7×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept halo:SharesAcquiredCommissionFeesCostPerShare.

The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001159036-26-000104

(1) Included in the total cost of shares purchased is a commission fee of $0.02 per share.

Item 1. Financial Statements

FAQ

What is Halozyme Therapeutics's shares acquired, commission fees, cost per share (in dollars per share)?
Halozyme Therapeutics (HALO) reported shares acquired, commission fees, cost per share (in dollars per share) of $0.02 in Q2 2026.
What does shares acquired, commission fees, cost per share (in dollars per share) mean?
Shares acquired, commission fees, cost per share (in dollars per share) as reported by Halozyme Therapeutics, Inc..

Ask your AI about Halozyme Therapeutics's shares acquired, commission fees, cost per share (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude